Jeena Sikho Lifecare Limited's Board of Directors conducted a meeting on December 23, 2025, at the company's registered office in Mohali, Punjab, to address significant changes in its internal audit structure. The board meeting, which commenced at 7:00 PM and concluded at 7:15 PM, focused on the transition of internal audit responsibilities.

Internal Auditor Resignation

The board formally accepted the resignation of M/s Deepak K Garg Associates, Chartered Accountants, from their position as Internal Auditor. The resignation was submitted via email on December 23, 2025, with the auditor citing pre-occupation with other professional commitments as the primary reason for stepping down.

The internal auditor confirmed that there were no material reasons for resignation other than those mentioned in the resignation communication. CA. Puneet Gupta, representing the firm, expressed gratitude for the opportunity and cooperation received during the tenure.

New Internal Auditor Appointment

Simultaneously, the board approved the appointment of M/s. Forvis Mazars LLP as the new Internal Auditor for the Financial Year 2025-26. The appointment ensures continuity in the company's internal audit processes and compliance requirements.

M/s. Forvis Mazars LLP is described as a leading international assurance, tax, and advisory firm that assists clients in achieving sustainable and responsible growth. The firm serves a wide range of industries with strong sector-specific understanding and offers a diverse portfolio of services that enhances the relevance and quality of its offerings.

Regulatory Compliance

The board meeting outcomes were communicated to both the National Stock Exchange of India Limited and BSE Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided detailed annexures containing additional disclosures as required under SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

The transition reflects the company's commitment to maintaining robust internal audit practices while ensuring compliance with regulatory requirements. The appointment of an established international firm demonstrates the company's focus on strengthening its governance framework for the upcoming financial year.

Jeena Sikho Lifecare Limited , a prominent player in the alternative healthcare sector, has reported robust financial results for the second quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Performance

The company's revenue from operations reached Rs. 190.00 crores in Q2FY26, marking a substantial 66% year-on-year growth from Rs. 114.00 crores in Q2FY25. This performance was complemented by a 9% quarter-over-quarter increase from Rs. 174.00 crores in Q1FY26.

Jeena Sikho's profitability saw a remarkable improvement, with profit after tax (PAT) surging 121% year-on-year to Rs. 59.00 crores. The company also reported a 15% quarter-over-quarter increase in PAT.

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) grew by 129% year-on-year to Rs. 92.00 crores, maintaining a strong EBITDA margin of 48%.

Operational Highlights

The healthcare provider has expanded its bed capacity, adding 582 beds to reach a total of 2,802 beds. The company reported a 57% occupancy rate across its network of 58 hospitals and 59 clinics.

Jeena Sikho's geographical footprint now spans 23 states and over 100 cities, indicating a wide-reaching presence in the Indian healthcare market.

Strategic Partnerships and Expansion

Jeena Sikho announced a strategic partnership with Chandan Diagnostic. This collaboration provides the company access to 40 lakh privilege cardholders and facilitates the establishment of diagnostic centers across their network.

The partnership aims to enhance patient services by offering free basic blood tests, including ESR, uric acid, CBC, lipid profile, LFT, RFT, and thyroid profile.

Product Development and Technology Integration

The company plans to launch 10 new over-the-counter (OTC) products by the end of the year, expanding its product portfolio. Additionally, Jeena Sikho has partnered with Salesforce to improve data management and customer engagement, indicating a focus on technological integration to enhance operational efficiency.

Management Commentary

Manish Grover, Managing Director of Jeena Sikho Lifecare Limited, commented on the results: "Our continuous hard work and effort has given a great result. We have observed good revenue growth in our product and services segment. This expansional growth shows that we are strongly motivated towards spreading quality alternate health care services to a lot of people."

Grover also highlighted the company's focus on increasing bed occupancy and expanding service footprint, stating, "We are seeing tremendous growth in both our product and services verticals. And it is proof that we are continuously increasing the free cash generation revenue generation."

Future Outlook

While specific guidance for the full fiscal year was not provided, management indicated ongoing efforts to maintain operational efficiency while pursuing expansion. The company's focus on increasing bed occupancy, launching new products, and strategic partnerships suggests a continued growth trajectory in the alternative healthcare sector.

Jeena Sikho Lifecare's strong Q2 FY26 performance underscores its growing presence in the alternative healthcare market, with significant improvements in revenue, profitability, and operational scale.